Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital West
mi
from
Pembroke Pines, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital West
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Emory University Midtown
mi
from
Atlanta, GA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Emory University Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Piedmont Hospital Atlanta
mi
from
Atlanta, GA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Piedmont Hospital Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Northwestern Memorial Hospital
mi
from
Chicago, IL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Advocate Christ Medical Center
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Johns Hospital
mi
from
Springfield, IL
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Johns Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Elkhart General Hospital
mi
from
Elkhart, IN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Elkhart General Hospital
mi
from
Elkhart, IN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Francisan St. Francis Health
mi
from
Indianapolis, IN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Francisan St. Francis Health
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Vincent Heart Center of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Jewish Hospital
mi
from
Louisville, KY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Jewish Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Baptist Hospital East - Louisville
mi
from
Louisville, KY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Baptist Hospital East - Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Ochsner Clinic
mi
from
New Orleans, LA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Ochsner Clinic
mi
from
New Orleans, LA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Eastern Maine Medical Center
mi
from
Bangor, ME
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Eastern Maine Medical Center
mi
from
Bangor, ME
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Maine Medical Center
mi
from
Portland, ME
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Maine Medical Center
mi
from
Portland, ME
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Union Memorial Hospital
mi
from
Baltimore, MD
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Union Memorial Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Washington Hospital Center
mi
from
Boston, MA
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Washington Hospital Center
mi
from
Boston, MA
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Bay Regional Medical Center
mi
from
Bay City, MI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Bay Regional Medical Center
mi
from
Bay City, MI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Oakwood Hospital
mi
from
Dearborn, MI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Oakwood Hospital
mi
from
Dearborn, MI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Harper University Hospital
mi
from
Detroit, MI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Harper University Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. John's Hospital and Medical Center
mi
from
Detroit, MI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. John's Hospital and Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Northern Michigan Hospital
mi
from
Petoskey, MI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Northern Michigan Hospital
mi
from
Petoskey, MI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Beaumont Hospitals
mi
from
Royal Oak, MI
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Beaumont Hospitals
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
North Mississippi Medical Center
mi
from
Tupelo, MS
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
North Mississippi Medical Center
mi
from
Tupelo, MS
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Boone Hospital Center
mi
from
Columbia, MO
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Boone Hospital Center
mi
from
Columbia, MO
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Mercy Hospital Springfield
mi
from
Springfield, MO
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Mercy Hospital Springfield
mi
from
Springfield, MO
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
St. Patrick Hospital
mi
from
Missoula, MT
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
St. Patrick Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Nebraska Heart Hospital
mi
from
Lincoln, NE
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Nebraska Heart Hospital
mi
from
Lincoln, NE
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Alegent Bergant - Omaha
mi
from
Omaha, NE
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Alegent Bergant - Omaha
mi
from
Omaha, NE
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Memorial Hospital
mi
from
Lebanon, NH
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Memorial Hospital
mi
from
Lebanon, NH
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Our Lady of Lourdes Medical Center
mi
from
Camden, NJ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Our Lady of Lourdes Medical Center
mi
from
Camden, NJ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Morristown Memorial MED CTR
mi
from
Morristown, NJ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Morristown Memorial MED CTR
mi
from
Morristown, NJ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Jersey Shore University Medical Center
mi
from
Neptune, NJ
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Queens Hospital
mi
from
Flushing, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Queens Hospital
mi
from
Flushing, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated:  12/31/1969
Strong Memorial Hospital
mi
from
Rochester, NY
Absorb IV Randomized Controlled Trial
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Status: Enrolling
Updated: 12/31/1969
Strong Memorial Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials